<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03023462</url>
  </required_header>
  <id_info>
    <org_study_id>AB3384</org_study_id>
    <nct_id>NCT03023462</nct_id>
  </id_info>
  <brief_title>Effectiveness of a Transmuscular Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair</brief_title>
  <official_title>Effectiveness of a Transmuscular Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ostfold Hospital Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ostfold Hospital Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      One of the most common complications after hernia repair is postoperative and chronic pain.
      TAP (transverse abdominis plain) block is a recommended multimodal method of reducing
      postoperative pain in laparoscopic and open inguinal hernia repair. The objective of this
      study is to determine whether the use of a perioperative echo guided unilateral TAP block has
      a superior effect on postoperative pain after laparoscopic inguinal repair compared to the
      transmuscular Quadratus Lumborum Block with a long acting local anesthetic.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One of the most common complications after hernia repair is postoperative and chronic pain.
      Postoperative pain is an expected but undesirable effect after an operation, which can result
      in an prolonged hospital stay or longer time to return fully to normal daily activities.
      There are indications that an insufficient treatment of postoperative pain is a risk factor
      for persistent or chronic pain after open and laparoscopic inguinal hernia repair (Berndsen
      FH 2007) (Nienhuijs SW 2005).

      TAP (transverse abdominis plain) block is a recommended multimodal method of reducing
      postoperative pain in laparoscopic and open surgery (El-Dawlatly AA 2009; 102). TAP block
      (Meyer A 2015) and a transmuscular Quadratus Lumborum Block (Adhikary, S.D. 2017) are both
      recommended for inguinal hernia repair. The objective of this study is to determine, whether
      the use of a perioperative echo guided unilateral TAP block has a superior effect on
      postoperative pain after laparoscopic inguinal repair compared to the transmuscular Quadratus
      Lumborum Block with a long acting local anesthetic. There will be no further analysis in this
      study regarding the evidence of open hernia inguinal repair and chronic pain.

      The primary endpoint:

      Opioid consumption measured in orale morphine equivalents four hours postoperative.

      The secondary endpoints:

      Opoioid consumption measured in orale morphine equivalents after 24 hours, 48 hours and seven
      days postoperative.

      Postoperative nausea and vomiting measured on a NRS scale 0-3. Sedation scores measured on a
      NRS scale 0-3.

      There will be conducted a telephone interview by a blinded study nurse at 24 h, 48 h and 7
      days, interviewing the patients as to their NRS score, nausea, sedation, level of activity
      and satisfaction with their overall treatment.

      Power and Sample Size Calculator There are little information in the litterature pertaining
      to the clinical significant difference in opioid consumption between the TAP block and the
      transmuscular QLB in inguinal hernia repair. We will as a consequence do a pilot study with
      30 patients to calculate a significant clinical difference and a standard deviation. The
      level of significanse will be set at α = 0,05 and an effect size of 90% (β = 0,1). There will
      be an independent researcher connected to the study that will do the interim analysis and
      give the total sample size from the formentioned analysis. If there are no clinical
      significant difference after 50 included patients, the inclusion will be halted as the
      difference then will be to small to be useful in daily clinical practise.

      Premedication: Paracetamol by weight (2 grams (g)&gt;70 kilos (kg) &lt;70 years, 1,5 g &lt;70 kg &gt;70
      years, 1 g &lt;50 kg) , Diclofenac by weight (100 milligrams (mg) &gt;70 kg &lt;70 years, 50 mg &lt;70 kg
      &gt;70 years).

      General anaesthesia: TCI (Target Control Infusion = Anesthesia protocol): Propofol and
      Remifentanil Surgical procedure: Laparoscopic inguinal hernia repair. 5 mg/ml 10 ml
      Ropivacaine in the ports peroperatively.

      Postoperatively:

        -  Oral paracetamol 1000 mg every 6 h

        -  In case of insufficient analgesia (NRS&gt;4) oxycodon 2-5 mg will be administered by a
           postoperative nurse.

        -  When nausea and vomiting occurs postoperatively, ondansetron 4 mg IV administers as the
           drug of first choice followed by droperidol 0,625 mg IV if the nausea/vomiting persists.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 20, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Group QLB: transmuscular Quadratus Lumborum Block using ropivacaine 7,5 mg/ml, 20ml. Subcutaneous wound infiltration in all patients with ropivacaine 5 mg/ml,10 ml.
Group TAP: Transversus abdominis plane block using ropivacaine 7,5 mg/ml, 20 ml Subcutaneous wound infiltration in all patients with ropivacaine 5 mg/ml,10 ml.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Computer generated randomization with allocation in opaque envelopes. Randomization performed by other study personell than care provider.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid consumption measured as orale morphine equivalents.</measure>
    <time_frame>0 - 4 hours</time_frame>
    <description>Differences in opioid consumption after four hours.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting</measure>
    <time_frame>0 - 7 days postoperative.</time_frame>
    <description>Nausea is measured by a NRS score 0-3 at the timepoints 4 hours, 24 hours, 48 hours and 7 days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation scores</measure>
    <time_frame>0 - 7 days postoperative.</time_frame>
    <description>Sedation is measured by a NRS score 0-3 at the timepoints 4 hours, 24 hours, 48 hours and 7 days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption measured in orale morphine equivalents.</measure>
    <time_frame>4 hours- 7 days postopertive.</time_frame>
    <description>Opioid consumption measured at 24 hours, 48 hours and seven days.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Inguinal Hernia</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Transmuscular Quadratus lumborum Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A single shot unilateral transmuscular Quadratus lumborum Block with Ropivacaine 7,5 mg/ml, 20 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TAP Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A single shot unilateral TAP block with Ropivacaine 7,5 mg/ml, 20 ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oksykodonhydroklorid</intervention_name>
    <description>Oksykodonhydroklorid, 5 - 10 mg intravenously or orally postoperatively to reduce pain. Repetition until effect.</description>
    <arm_group_label>TAP Block</arm_group_label>
    <arm_group_label>Transmuscular Quadratus lumborum Block</arm_group_label>
    <other_name>oxycodone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ondansetron and Droperidol</intervention_name>
    <description>When nausea and vomiting: Ondansetron 4mg and droperidol 0,625 mg intravenously</description>
    <arm_group_label>TAP Block</arm_group_label>
    <arm_group_label>Transmuscular Quadratus lumborum Block</arm_group_label>
    <other_name>Ondansetron and Dridol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Local anesthetic for the block</description>
    <arm_group_label>TAP Block</arm_group_label>
    <arm_group_label>Transmuscular Quadratus lumborum Block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria;

          -  Age &gt; 18 years

          -  BMI (body mass index) 20-35

          -  ASA (American Association of Anesthesiologists Classification system for physical
             status) I-III.

          -  Scheduled for elective laparoscopic inguinal hernia operation

        Exclusion criteria:

          -  Allergy to latex, local anesthesia or opioids

          -  Chronic pain with daily opiate use

          -  Patients with severe renal and/or hepatic disease

          -  Local infection at the site of injection

          -  Systemic infection

          -  AV block 2-3

          -  Inability to understand written or spoken Norwegian

          -  Inability to cooperate

          -  Dementia

          -  Known abuse of alcohol or medication

          -  Coagulation disorder

          -  Pregnancy Previously operated with same side operation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Sverre Vamnes, MD, Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Senior consultant</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jan Sverre Vamnes, MD, Ph.D.</last_name>
    <phone>+47 913 050 16</phone>
    <email>jan.sverre.vamnes@so-hf.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie Sørenstua, MD</last_name>
    <phone>+47 9097 68 830</phone>
    <email>marie.sorenstua@so-hf.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ostfold Hospital Trust, Moss</name>
      <address>
        <city>Moss</city>
        <state>Ostfold</state>
        <zip>1500</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Sverre Vamnes, MD, Ph.D.</last_name>
      <phone>+47 91608896</phone>
      <email>janvam@so-hf.no</email>
    </contact>
    <contact_backup>
      <last_name>Knut Inge Solbakk, md</last_name>
      <phone>+47 90933106</phone>
      <email>knisol@so-hf.no</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <reference>
    <citation>Berndsen FH, Petersson U, Arvidsson D, Leijonmarck CE, Rudberg C, Smedberg S, Montgomery A; SMIL Study Group. Discomfort five years after laparoscopic and Shouldice inguinal hernia repair: a randomised trial with 867 patients. A report from the SMIL study group. Hernia. 2007 Aug;11(4):307-13. Epub 2007 Apr 18.</citation>
    <PMID>17440795</PMID>
  </reference>
  <reference>
    <citation>El-Dawlatly AA, Turkistani A, Kettner SC, Machata AM, Delvi MB, Thallaj A, Kapral S, Marhofer P. Ultrasound-guided transversus abdominis plane block: description of a new technique and comparison with conventional systemic analgesia during laparoscopic cholecystectomy. Br J Anaesth. 2009 Jun;102(6):763-7. doi: 10.1093/bja/aep067. Epub 2009 Apr 17. Erratum in: Br J Anaesth. 2009 Oct;103(4):622.</citation>
    <PMID>19376789</PMID>
  </reference>
  <reference>
    <citation>Meyer A, Bonnet L, Bourbon M, Blanc P. Totally extraperitoneal (TEP) endoscopic inguinal hernia repair with TAP (transversus abdominis plane) block as a day-case: a prospective cohort study. J Visc Surg. 2015 Jun;152(3):155-9. doi: 10.1016/j.jviscsurg.2014.12.005. Epub 2015 Jan 6.</citation>
    <PMID>25575582</PMID>
  </reference>
  <reference>
    <citation>Nienhuijs SW, Boelens OB, Strobbe LJ. Pain after anterior mesh hernia repair. J Am Coll Surg. 2005 Jun;200(6):885-9.</citation>
    <PMID>15922201</PMID>
  </reference>
  <reference>
    <citation>Petersen PL, Mathiesen O, Stjernholm P, Kristiansen VB, Torup H, Hansen EG, Mitchell AU, Moeller A, Rosenberg J, Dahl JB. The effect of transversus abdominis plane block or local anaesthetic infiltration in inguinal hernia repair: a randomised clinical trial. Eur J Anaesthesiol. 2013 Jul;30(7):415-21. doi: 10.1097/EJA.0b013e32835fc86f.</citation>
    <PMID>23549122</PMID>
  </reference>
  <reference>
    <citation>Adhikary SD, El-Boghdadly K, Nasralah Z, Sarwani N, Nixon AM, Chin KJ. A radiologic and anatomic assessment of injectate spread following transmuscular quadratus lumborum block in cadavers. Anaesthesia. 2017 Jan;72(1):73-79. doi: 10.1111/anae.13647. Epub 2016 Oct 12.</citation>
    <PMID>27730633</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>January 3, 2017</study_first_submitted>
  <study_first_submitted_qc>January 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 18, 2017</study_first_posted>
  <last_update_submitted>June 4, 2020</last_update_submitted>
  <last_update_submitted_qc>June 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Transmuscular Quadratus Lumborum block</keyword>
  <keyword>Transversus Abdominis block</keyword>
  <keyword>Truncal block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Droperidol</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
    <mesh_term>Ondansetron</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>No sharing plan so far</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

